Argenica Therapeutics Limited (ASX:AGN)
Australia
· Delayed Price · Currency is AUD
0.210
+0.010 (5.00%)
Mar 10, 2026, 1:54 PM AEST
Argenica Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -9.8 | -7.17 | -5.48 | -4.82 | -4.09 | -1.03 | |
| Stock-Based Compensation | 0.11 | 0.11 | 0.14 | 0.46 | 0.43 | 0.27 | |
| Change in Accounts Receivable | -0.03 | -0.03 | -0.23 | -0.07 | -0 | -0.09 | |
| Change in Accounts Payable | 1.47 | 1.47 | 0.45 | 0.46 | 0.29 | -0.2 | |
| Change in Unearned Revenue | -0.09 | -0.09 | 0.05 | 0.66 | - | - | |
| Change in Other Net Operating Assets | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | |
| Operating Cash Flow | -10.04 | -5.7 | -5.06 | -3.3 | -3.36 | -1.05 | |
| Investment in Securities | - | - | 0.05 | -0.05 | - | - | |
| Investing Cash Flow | - | - | 0.05 | -0.05 | - | - | |
| Issuance of Common Stock | - | 0.35 | 11.63 | 3.73 | 5.13 | 7.85 | |
| Other Financing Activities | 0.02 | - | - | 0 | 0 | 0 | |
| Financing Cash Flow | 0 | 0.35 | 11.63 | 3.73 | 5.13 | 7.85 | |
| Net Cash Flow | -10.04 | -5.36 | 6.62 | 0.37 | 1.77 | 6.8 | |
| Cash Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash Income Tax Paid | - | -2.76 | -2.09 | -1.38 | -0.26 | -0.15 | |
| Levered Free Cash Flow | -6.57 | -3.34 | -3.11 | -1.52 | -1.82 | -0.4 | |
| Unlevered Free Cash Flow | -6.57 | -3.34 | -3.11 | -1.52 | -1.82 | -0.4 | |
| Change in Working Capital | 1.36 | 1.36 | 0.28 | 1.05 | 0.3 | -0.29 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.